Franz-Werner Haas
Chief Executive Officer bij Curevac Aktiebolag
Vermogen: 443 986 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Franz-Werner Haas
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
21
| Public Company | Pharmaceuticals: Major | 21 |
LimmaTech Biologics AG
 LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
| Public Company | Financial Conglomerates | 4 | |
Lion Bioscience, Inc.
 Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
| Extinct | Medical Specialties | 1 | |
Curevac Aktiebolag
 Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The private company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012.
1
| Subsidiary | Containers/Packaging | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Franz-Werner Haas via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Glycomed, Inc.
 Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Glycomed, Inc. discovers and developes pharmaceuticals based on complex carbohydrates. The company's drug discovery strategy utilizes medicinal chemistry to identify biologically active small molecules for therapeutic use. The company was founded by Brian G. Atwood in 1987 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IKARIA, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member Director of Finance/CFO Founder Founder Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AFFIMED N.V. | Biotechnology | Chief Administrative Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Freiburg | College/University | Doctorate Degree Doctorate Degree | |
| University of British Columbia | College/University | Doctorate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Carleton University | College/University | Undergraduate Degree | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| University of Mannheim | College/University | Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Ernst & Young AG Wirtschaftsprüfungsgesellschaft
 Ernst & Young AG Wirtschaftsprüfungsgesellschaft Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AG Wirtschaftsprüfungsgesellschaft is a private company based in Munich, Germany. The German company offers managed services that revolutionize non-core business tasks that are essential for the company. The company has four integrated business areas, including assurance and audit-related services, tax consulting, business consulting, and strategy and transactions. With their industry knowledge, they support their clients in developing new business models and assessing risks to promote sustainable growth. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| Fachhochschule Ludwigshafen am Rhein | College/University | Corporate Officer/Principal Graduate Degree | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
| Otto-von-Guericke-Universität Magdeburg | College/University | Doctorate Degree | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Chief Executive Officer | |
GEUDER AG
 GEUDER AG Medical SpecialtiesHealth Technology GEUDER AG manufactures ophthalmic surgical instruments and systems. Its products include eye specula, retractors, foreign body instruments, scissors, forceps, needle holders and sterilization containers and adapters. The company was founded by Hans Geuder, Sr. in 1951 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree | |
Global Health Investment Fund
 Global Health Investment Fund Investment ManagersFinance Global Health Investment Fund seeks investment opportunities in global health technologies. The fund invests in new drugs & vaccines, emerging diagnostic tools, child-friendly formulations of existing products, expanding manufacturing capacity and other applications. It provides financing in the form of mezzanine for later-stage capital requirements. | Investment Managers | Private Equity Analyst | |
dievini patch Beteiligungs GmbH
 dievini patch Beteiligungs GmbH Financial ConglomeratesFinance dievini patch Beteiligungs GmbH provides investment services. The company is headquartered in Andernach, Germany. | Financial Conglomerates | Chief Executive Officer | |
| COSMO PHARMACEUTICALS N.V. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
 TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG is a German company based in Walldorf, Germany. TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG provides real estate services. The private company was founded in 2008, and its CEOs are Dietmar Hopp, Oliver Hopp, and Mathias Hothum. | Real Estate Development | Chief Executive Officer | |
| African Research Excellence Fund | Director/Board Member | ||
Frontier Nutrition, Inc.
 Frontier Nutrition, Inc. Food: Specialty/CandyConsumer Non-Durables Frontier Nutrition, Inc. develops and manufactures fortified packaged food. Its recipes are localized for traditional diets, taste, and nutrition. The company was founded by Eddie Bearnot and Tanveer Ali on August 18, 2016 and is headquartered in DE. | Food: Specialty/Candy | Director/Board Member | |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Founder | |
| Hmm Consulting | Chief Executive Officer | ||
| AN2 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member Chief Executive Officer | |
Quantoom Biosciences SA
 Quantoom Biosciences SA Pharmaceuticals: OtherHealth Technology Quantoom Biosciences SA is a Belgian company that is focused on revolutionizing mRNA production through the development of their platform, ntensify. The private company is based in Nivelles, Belgium. This platform includes DNA amplification and RNA manufacturing, with the ntensify systems being the core of their RNA production technology. The company is made up of a team of scientists, engineers, and clinicians who are dedicated to addressing the major challenges in DNA and RNA production for vaccines and therapeutics. | Pharmaceuticals: Other | Director/Board Member |
Statistieken
Internationaal
| Duitsland | 23 |
| Verenigde Staten | 9 |
| Zwitserland | 5 |
| Italië | 4 |
| Canada | 3 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 11 |
| Finance | 6 |
| Commercial Services | 5 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 170 |
| Chairman | 65 |
| Corporate Officer/Principal | 64 |
| Chief Executive Officer | 29 |
| Independent Dir/Board Member | 24 |
Sterkste connecties
| Insiders | |
|---|---|
| Friedrich von Bohlen und Halbach | 36 |
| Baron Jean Stéphenne | 36 |
| Timothy Sullivan | 34 |
| Carsten Nils Erik Browall | 27 |
| Hans Tanner | 24 |
| Craig Tooman | 22 |
| Mathias Hothum | 19 |
| Philippe Dro | 18 |
| Klaus Schollmeier | 17 |
| Ralf Clemens | 14 |
| Timothy M. Wright | 13 |
| Kabeer Aziz | 12 |
| Debra Stephanie Barker | 11 |
| Kevin Holme | 8 |
| Igor Splawski | 8 |
- Beurs
- Insiders
- Franz-Werner Haas
- Bedrijfsconnecties
